---
title: "DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295007946.md"
description: "Q2 2026 revenue fell 48% year-over-year to $20 million, with a net loss from continuing operations of $(57) million and Adjusted EBITDA of $(36) million. Major government contracts were secured for autonomous labs, and full-year cash burn is expected between $(150) million and $(125) million.Original document: Ginkgo Bioworks Holdings, Inc. [DNA] SEC 8-K Current Report — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T20:13:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295007946.md)
  - [en](https://longbridge.com/en/news/295007946.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295007946.md)
---

# DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured

Q2 2026 revenue fell 48% year-over-year to $20 million, with a net loss from continuing operations of $(57) million and Adjusted EBITDA of $(36) million. Major government contracts were secured for autonomous labs, and full-year cash burn is expected between $(150) million and $(125) million.

Original document: Ginkgo Bioworks Holdings, Inc. \[DNA\] SEC 8-K Current Report — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [DNA.US](https://longbridge.com/en/quote/DNA.US.md)
- [DNABW.US](https://longbridge.com/en/quote/DNABW.US.md)

## Related News & Research

- [DNA X delays Q2 10-Q filing, cites convertible debt and consolidation accounting complexities](https://longbridge.com/en/news/295970722.md)
- [DNA X amends 8-K to update disclosure on Series B preferred stock sale for $2.5 million](https://longbridge.com/en/news/295838356.md)
- [Appian (APPN) Q2 2026 Earnings Call Transcript](https://longbridge.com/en/news/295830569.md)
- [FOCL: Q2 2026 revenue up 39% to $13.2M; gross margin 55.6%; net loss $14.4M; 2026 guidance reiterated](https://longbridge.com/en/news/295839337.md)
- [2Invest AG schedules release of half-year 2026 report](https://longbridge.com/en/news/295943641.md)